Medical termination of pregnancy at 63 to 83 days gestation
Authors:
Open Access
- 1 June 1999
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 106 (6) , 535-539
Abstract
Objective To assess the efficacy of a medical regimen for the termination of pregnancy within the gestational age range of 63 to 83 days.Design Prospective observational study.Setting Gynaecology department within a district general hospital.Population Women attending t0068e pregnancy advisory clinic between June 1996 and December 1997.Methods The medical regimen used was mifepristone 200 mg orally followed after 36 to 48 h by misoprostol 800 μg administered vaginally.Main outcome measures The success rate of the medical termination of pregnancy regimen, where success was defined as achieving complete abortion without the need for secondary intervention by either surgical or repeat medical means.Results Primary medical termination of pregnancy was chosen by 253 (80.8%) of the 313 women and was successful in 239 (94.5%). Repeat medical treatment achieved completion of the abortion in a further three women (1.2%) and surgical evacuation of the uterus was required in 10 (4.0%). One woman declined further intervention after failed medical treatment but subsequently miscarried.Conclusions The combination of mifepristone and misoprostol is effective for the termination of pregnancy for gestations of 63 to 83 days.Keywords
This publication has 16 references indexed in Scilit:
- Early Pregnancy Termination with Mifepristone and Misoprostol in the United StatesNew England Journal of Medicine, 1998
- Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancyObstetrics & Gynecology, 1997
- The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicentre study—Final resultsContraception, 1997
- Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostolEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of EdinburghBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal MisoprostolNew England Journal of Medicine, 1995
- Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.BMJ, 1993
- Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin MisoprostolNew England Journal of Medicine, 1993
- Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprostContraception, 1993
- Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost)Contraception, 1989